FDA Inspection 910004 — Zhejiang Haisen Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Haisen Pharmaceutical Co., Ltd. on Dec 12, 2014 in Dongyang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dongyang (China)